CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.5290
-0.0049 (-0.92%)
At close: Apr 2, 2026, 4:00 PM EDT
0.4814
-0.0476 (-9.00%)
After-hours: Apr 2, 2026, 7:52 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Biotechnology
2.37M515.00K10.96M299.00K15.64M
Biotechnology Growth
360.39%-95.30%3565.22%-98.09%154.86%
Total
2.37M515.00K10.96M299.00K15.64M
Total Growth
360.39%-95.30%3565.22%-98.09%154.86%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
2.18M484.00K10.84M16.00K14.95M
United States Growth
349.59%-95.53%67643.75%-99.89%-
Canada
96.00K-87.00K158.00K57.00K
Canada Growth
---44.94%177.19%-
Europe and Other
98.00K-28.00K104.00K633.00K
Europe and Other Growth
---73.08%-83.57%-
Israel
1,000.0031.00K5.00K21.00K-
Israel Growth
-96.77%520.00%-76.19%--
Total
2.37M515.00K10.96M299.00K15.64M
Total Growth
360.39%-95.30%3565.22%-98.09%154.86%
Source: S&P Global Market Intelligence.